| Phagocytosis in the brain: homeostasis and disease DA Galloway, AEM Phillips, DRJ Owen, CS Moore Frontiers in immunology 10, 448505, 2019 | 287 | 2019 |
| Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans DR Owen, N Narayan, L Wells, L Healy, E Smyth, EA Rabiner, ... Journal of Cerebral Blood Flow & Metabolism 37 (8), 2679-2690, 2017 | 190 | 2017 |
| miRNAs as emerging regulators of oligodendrocyte development and differentiation DA Galloway, CS Moore Frontiers in cell and developmental biology 4, 59, 2016 | 67 | 2016 |
| MicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis B Morquette, CA Juźwik, SS Drake, M Charabati, Y Zhang, MA Lécuyer, ... Brain 142 (10), 2979-2995, 2019 | 64 | 2019 |
| T he roles of extracellular vesicle micro RNA s in the central nervous system SN Blandford, DA Galloway, CS Moore Glia 66 (11), 2267-2278, 2018 | 60 | 2018 |
| miR‐223 promotes regenerative myeloid cell phenotype and function in the demyelinated central nervous system DA Galloway, SN Blandford, T Berry, JB Williams, M Stefanelli, ... Glia 67 (5), 857-869, 2019 | 47 | 2019 |
| Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases E Nutma, N Fancy, M Weinert, S Tsartsalis, MC Marzin, RCJ Muirhead, ... Nature communications 14 (1), 5247, 2023 | 43 | 2023 |
| Effects of fumarates on inflammatory human astrocyte responses and oligodendrocyte differentiation DA Galloway, JB Williams, CS Moore Annals of Clinical and Translational Neurology 4 (6), 381-391, 2017 | 41 | 2017 |
| Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination DA Galloway, E Gowing, S Setayeshgar, R Kothary Glia 68 (5), 859-877, 2020 | 21 | 2020 |
| TAAR1 expression in human macrophages and brain tissue: a potential novel facet of MS neuroinflammation DA Barnes, DA Galloway, MC Hoener, MD Berry, CS Moore International Journal of Molecular Sciences 22 (21), 11576, 2021 | 20 | 2021 |
| Interleukin-1 receptor antagonist: An exploratory plasma biomarker that correlates with disability and provides pathophysiological insights in relapsing-remitting multiple … SN Blandford, DA Galloway, JB Williams, S Arsenault, J Brown, ... Multiple Sclerosis and Related Disorders 52, 103006, 2021 | 12 | 2021 |
| Investigating the NLRP3 inflammasome and its regulator miR‐223‐3p in multiple sclerosis and experimental demyelination DA Galloway, SJ Carew, SN Blandford, RY Benoit, NJ Fudge, T Berry, ... Journal of Neurochemistry 163 (2), 94-112, 2022 | 8 | 2022 |
| Phagocytosis in the Brain: Homeostasis and Disease. Front Immunol. 2019; 10: 790 DA Galloway, AEM Phillips, DRJ Owen, CS Moore | 4 | 2019 |
| MicroRNA-223 protects neurons from degeneration in Experimental Autoimmune Encephalomyelitis B Morquette, CA Juźwik, SS Drake, M Charabati, Y Zhang, MA Lécuyer, ... bioRxiv, 430777, 2018 | 2 | 2018 |
| Il-1 Receptor Antagonist: A Novel Soluble Biomarker that Correlates with Disabilty and Neurofilament Light in Multiple Sclerosis SN Blandford, D Galloway, JB Williams, S Arsenault, J Brown, G MacLean, ... MULTIPLE SCLEROSIS JOURNAL 27 (1_ SUPPL), 24-24, 2021 | | 2021 |
| Investigating NLRP3 Inflammasome Activation and Regulation in Multiple Sclerosis and Experimentally-Induced Demyelination D Galloway, C Moore MULTIPLE SCLEROSIS JOURNAL 27 (1_ SUPPL), 103-104, 2021 | | 2021 |
| Investigating microRNA-mediated glial cell contributions in the pathophysiology of MS and its animal models DA Galloway Memorial University of Newfoundland, 2021 | | 2021 |
| NLRP3 inflammasome activation in multiple sclerosis and experimentally-induced demyelination D Galloway, J Williams, T Berry, C Moore MULTIPLE SCLEROSIS JOURNAL 25, 218-218, 2019 | | 2019 |
| Plasma interleukin-1 receptor antagonist (IL-1RA) correlates with EDSS and is a putative marker of transition to secondary progressive multiple sclerosis SN Blandford, JB Williams, DA Galloway, J Brown, M Ploughman, F Clift, ... MULTIPLE SCLEROSIS JOURNAL 25, 721-721, 2019 | | 2019 |
| NLRP3 Inflammasome Activation Contributes to Inflammatory and Demyelinating Injury in MS. DA Galloway, SN Blandford, JB Williams, T Berry, CS Moore ACTRIMS Forum 2019, 2019 | | 2019 |
